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Abstract
Introduction: Currently there is no generalized approach to treating patients with intra-medullary spinal
metastasis. High cervical spinal cord lesions can be particularly challenging cases, and may even be considered
inoperable by some.
Case report: We present what is, to the best of our knowledge, the first reported case of ovarian carcinoma
(managed primarily with surgery) in a 65-year-old Caucasian woman metastasizing to the upper cervical spinal
cord; we also review the relevant literature and discuss management strategies.
Conclusions: Due to improving systemic cancer therapies, patients with cancer now often survive longer and are
more likely to develop central nervous system metastases. Therefore, neurosurgical oncologists are often
challenged with difficult decisions about how to surgically manage these patients. We recommend individualized
multidisciplinary management based on patient functional status, the need for definitive diagnosis for possible
additional adjuvant therapies, and consideration of extent of systemic disease impacting on desirable quality and
length of survival.
Introduction
Whereas lung and breast cancer represent the most fre-
quently occurring spinal intra-medullary metastatic neo-
plasms, other solid tumors such as ovarian carcinoma
can also rarely metastasize to the spinal cord. On ima-
ging studies, the differential diagnoses for intra-medul-
lary spinal lesions can include gliomas and vascular
malformations but rare spinal infections such as tuber-
culosis can still be seen in some parts of the world [1,2].
The clinical presentation can range from minor neurolo-
gical symptoms to major symptoms that significantly
alter a patient’s daily activities.
Surgical resection of intramedullary spinal metastases
can be associated with significant morbidity. Manage-
ment must therefore be individualized based on patient
functional status, need for definitive diagnosis to guide
additional therapies, and extent of systemic disease
impacting on quality and length of survival. Previous
reports have described management strategies for ovar-
ian metastases to the spinal cord. However, we describe
the first ever report of a high cervical ovarian metastasis
managed primarily with surgery. Such an operation has
potential airway and brainstem complications. As
patients with cancer are surviving their primary disease
longer, neurosurgical oncologists may be faced with the
challenge of treating what were traditionally believed to
be inoperable lesions. A careful discussion with the
patient and their family, combined with multidisciplin-
ary input from colleagues from medical and radiation
oncology are important.
Case presentation
A 65-year-old Caucasian woman underwent surgery for
papillary serous ovarian adenocarcinoma involving both
ovaries and with extensive metastases (stage IIIC). An
exploratory laparotomy with total abdominal hysterect-
omy, bilateral salpingo-oophorectomy, and omentectomy
with cancer staging was performed. She also underwent
chemotherapy including carboplatin, paclitaxel, and cis-
platin. Her CA-125 level was normal and there was no
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evidence of disease progression at her last clinic visit at
our center. Then, two years later, she re-presented with
progressive neurological symptoms starting initially with
limb dysesthesias and numbness and progressing to
quadriparesis with urinary retention.
Imaging studies of her spine revealed an enhancing
heterogeneous C2-C5 intramedullary lesion with cord
expansion and edema extending rostrally into the
medulla and caudally to the thoracic spinal cord (Figure
1a). Serum CA-125 was normal at presentation and a
computed tomography (CT) scan of the chest, abdomen,
and pelvis were negative for other lesions. An investiga-
tion for possible sources of infection was negative.
Informed consent was obtained from our patient for
open surgical biopsy and possible debulking. C2-C5
laminectomies were performed for planned ultrasound-
guided dorsal midline biopsy and debulking of the intra-
medullary mass. The tumor was debulked and the rem-
nants of the tumor capsule dissected along the rostral
and caudal margins with care taken not to injure the
surrounding spinal cord. Somatosensory and motor
evoked potentials did not change during surgery. A
post-operative MRI scan showed the expected near total
resection and expected post-laminectomy changes with-
out any associated hematoma (Figure 1b,c). Pathologic
analysis revealed histological and cytological features
consistent with papillary serous ovarian adenocarcinoma
(Figure 2), similar to the pathological specimen from
her prior surgery. She made functional improvements
after surgery and was transferred to the rehabilitation
service. She gained the ability to stand with assistance
using a walker, had antigravity strength in her lower
extremities and 4/5 strength in her upper extremities.
Fractionated radiotherapy was initiated immediately in
the post-operative period during her rehabilitation.
Our patient had improvement in strength post-opera-
tively but required an emergency re-operation three
weeks later due to sudden paraplegia secondary to spinal
epidural hematoma, after therapy with prophylactic sub-
cutaneous heparin administration. On discharge a week
after epidural hematoma evacuation, she experienced
numbness below the umbilicus and slightly improved to
left toe movement. Unfortunately, our patient died five
months after discovery of her spinal metastasis, presum-
ably from a pulmonary embolism.
Discussion
Review of the English language literature via PubMed
database searches revealed five previous case reports of
spinal cord ovarian cancer metastases, of which only
three were tissue confirmed. Data from our report and
the literature are summarized in Table 1.
Our patient’s case is only the third reported tissue-
proven case of ovarian carcinoma metastasizing to the
spinal cord and the first reported case of metastasis to
the high cervical spinal cord. Historically, there has
been a role for surgery in resecting a solitary metastatic
lesion to the spinal cord. The limitations to surgical
resection are guided by the risk of morbidity to the
patient, especially with regards to neurological function.
Sundaresan et al. [3] retrospectively reviewed 80
patients with solitary spinal metastasis from all cancer
histologies. Overall median survival in that series follow-
ing surgery was 30 months. Survival was superior in the
group with breast and kidney cancers. Morbidity and
recurrence, however, were higher in patients receiving
prior radiation therapy. Indications for surgery include
pathological diagnosis, restoration of neurological func-
tion via decompression of mass effect and spinal stabili-
zation [3].
Figure 1 Sagittal cervical spine MRI. (a) Pre-surgical resection, T1 post-contrast demonstrating a 1.3 × 4.4 cm intramedullary enhancing mass
(left panel). (b) Post-surgical resection, T1 pre-contrast (middle panel). (c) Post-surgical resection, T1 post-contrast showing small amount of
residual tumor at caudal margin of tumor (right panel).
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The degree of tumor resection must be individualized.
Rastelli et al. [4] reported gross total resection in a T11
metastatic ovarian cancer. This patient had near-com-
plete strength improvement and MRI showed no spinal
recurrence 16 months later. Even in the two cases of
subtotal resection reviewed, tissue diagnosis is achieved
while also achieving a less morbid operation as deemed
appropriate by the involved surgeon. Isoyo et al. [5] per-
formed a subtotal resection of a T10 metastatic ovarian
lesion. This patient had no improvement in neurological
status but remained alive two years after surgery.
Steroids are beneficial because it provides sympto-
matic relief and reduces peri-tumoral edema with a low
side effect profile. The other case reports reviewed also
described a 30Gy radiation dose as a preferred prescrip-
tion for ovarian cancer spinal cord metastases. In select
cases, simultaneous steroids and radiotherapy adminis-
tration without a tissue diagnosis can be considered for
Figure 2 Hematoxylin and eosin stained section of cervical intramedullary tumor. This metastatic neoplasm was compared with prior
hysterectomy and salpingo-oophorectomy of our patient and reveals similar histologic and cytologic features to the ovarian papillary serous
adenocarcinoma.
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C6-T1 Four and a half years None 30Gy and steroids Strength improved; died six months later
Cormio et
al. [8]
C5-C6 One and a half years None Steroids, chemotherapy,
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Strength improved; died 10 months later
Isoya et al.
[5]
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*Approximate time in some cases based on estimates provided in reference.
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patients at high surgical risk with poor Karnovsky scores
[6,7]. Cormio et al. [8] demonstrated complete resolu-
tion of neurological symptoms with early steroids and
carboplatin. Prior to the fourth cycle of carboplatin, an
MRI scan of the brain showed diffuse metastatic disease
for which the patient received 30Gy radiotherapy to the
brain and cervical spine. In the above case report, how-
ever, no tissue diagnosis confirmation was obtained. The
MRI scan performed after radiotherapy demonstrated
almost complete resolution of the cervical lesion. Thus,
steroids combined with chemotherapy and radiotherapy
can be a viable empiric, alternative treatment regimen in
high-risk surgical patients. Symptomatic and imaging
responses in such cases, however, do not establish the
diagnosis of ovarian spinal metastasis.
Conclusions
There is no current consensus on management of
patients presenting with neurological symptoms and a
potential diagnosis of spinal intramedullary metastasis.
In cases of central nervous system spinal cord metas-
tases in patients experiencing progressive neurological
symptoms whose medical condition permit surgery, we
advocate open surgical biopsy with resection to confirm
tissue diagnosis, to reduce tumor burden for adjuvant
therapies while minimizing surgical morbidity, and to
accurately diagnose and treat non-metastatic diseases
that may masquerade as intramedullary spinal metas-
tases. The risks and benefits of such interventions, how-
ever, must be carefully weighed in discussions with
individual patients and their families. As patients with
cancer are surviving their primary disease longer, it will
be critical for neurosurgical oncologists to work closely
with radiation oncologists and medical oncologists to
formulate individualized treatment plans for patients
with central nervous system metastases, based on risk/
benefit analysis while also considering a patient’s desire
for quality of life and potential extent of survival.
Consent
Written informed consent was obtained from the
patient’s next-of-kin for publication of this case report
and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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